Prosecution Insights
Last updated: October 02, 2026

Bruker Spatial Biology Inc.

Technology area: Biotechnology & Pharmaceuticals

4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Bruker Spatial Biology Inc. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct art units and 4 distinct examiners. This distribution indicates that each of the 4 pending actions is being reviewed by a different individual.

SPENCE, JENNIFER SUZANNE is the busiest examiner for the company, with 1 pending office action currently under review. This is one of the 4 total pending actions for the portfolio. The involvement of 4 distinct examiners across 3 distinct art units for the pending actions suggests a diverse prosecution landscape for the company's current matters. Practitioners should expect that each of the 4 pending actions will be handled independently, with minimal concentration across the 3 art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (25%)
2
Medium (50%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§103 only2 (50%)
§112 only1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SPENCE, JENNIFER SUZANNE 1 66.9% +46.0%
MONTGOMERY, ANN Y 1 69.0% +27.7%
BEVERIDGE, CONNOR HAMMOND 1 0.0% +0.0%
KIM, SEONG JONG 1 25.0% +0.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18172771 CHEMICAL COMPOSITIONS AND METHODS OF USE KIM, SEONG JONG 8d overdue
18030889 METHODS, SYSTEMS AND DEVICES FOR PROCESSING SEQUENCE DATA BEVERIDGE, CONNOR HAMMOND —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18673148 FUNCTIONALIZED WELL PLATE, METHODS OF PREPARATION AND USE THEREOF SPENCE, JENNIFER SUZANNE 1d overdue
18332207 Methods for Identification of Exchangeable MHC Binding Peptides and Methods of Use Thereof MONTGOMERY, ANN Y —

Top Art Units

Art UnitApps
1633 1
1678 1
1621 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18673148 FUNCTIONALIZED WELL PLATE, METHODS OF PREPARATION AND USE THEREOF SPENCE, JENNIFER SUZANNE 1633 §103 Final Rejection 1d overdue Pending May 23, 2024
18332207 Methods for Identification of Exchangeable MHC Binding Peptides and Methods of Use Thereof MONTGOMERY, ANN Y 1678 §112 Non-Final OA — Pending Jun 09, 2023
18030889 METHODS, SYSTEMS AND DEVICES FOR PROCESSING SEQUENCE DATA BEVERIDGE, CONNOR HAMMOND — §101§103 Non-Final OA — Pending Apr 07, 2023
18172771 CHEMICAL COMPOSITIONS AND METHODS OF USE KIM, SEONG JONG 1621 §103Other Final Rejection 8d overdue Pending Feb 22, 2023

Managing Bruker Spatial Biology Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month